Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines
Authors:
- Jun HamaguchiJHJun Hamaguchi
- Hiroaki NakagawaHNHiroaki Nakagawa
- Masato TakahashiMTMasato Takahashi
- Takeaki KudoTKTakeaki Kudo
- Naoya KamiyamaNKNaoya Kamiyama
- Bailong SunBSBailong Sun
- Takahiro OshimaTOTakahiro Oshima
- Yuji SatoYSYuji Sato
- Kisaburo DeguchiKDKisaburo Deguchi
- Satoru TodoSTSatoru Todo
- Shin-Ichiro NishimuraSNShin-Ichiro Nishimura
Open Access
- 21 September 2007
- journal article
- Published by Springer Nature in Molecular Cancer
- Vol. 6 (1) , 58
Abstract
Background: Drug resistance is a major problem in cancer chemotherapy. Acquisition of chemo-resistance not only reduces the effectiveness of drugs, but also promotes side effects and markedly reduces the patient's quality of life. However, a number of resistance mechanisms have been reported and are thought to be the reason for the difficulties in solving drug-resistance problems. Result: To investigate the mechanisms of drug resistance, a set of cell lines with different levels of sensitivity and possessing different mechanisms of resistance to 5-fluorouracil (5-FU) was established from a colorectal cancer cell line. The expression of thymidylate synthase, orotic acid phosphoribosyltransferase and dihydropyrimidine dehydrogenase, which are well known to be related to drug resistance, differed among these cell lines, indicating that these cell lines acquired different resistance mechanisms. However, swainsonine, an inhibitor of N-glycan biosynthesis, reduced 5-FU-tolerance in all resistant cells, whereas the sensitivity of the parental cells was unchanged. Further analysis of the N-glycan profiles of all cell lines showed partial inhibition of biosynthesis and no cytotoxicity at the swainsonine dosage tested. Conclusion: These observations suggest that N-linked oligosaccharides affect 5-FU resistance more widely than do drug-resistance related enzymes in colorectal cancer cells, and that the N-glycan could be a universal target for chemotherapy. Further, swainsonine may enhance the performance of chemotherapy by reducing tolerance.Keywords
This publication has 47 references indexed in Scilit:
- N-glycan alterations are associated with drug resistance in human hepatocellular carcinomaMolecular Cancer, 2007
- Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cellsCancer Cell International, 2007
- Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptorProceedings of the National Academy of Sciences, 2006
- Unusual N-Glycan Structures in α-Mannosidase II/IIx Double Null Embryos Identified by a Systematic Glycomics Approach Based on Two-dimensional LC Mapping and Matrix-dependent Selective Fragmentation Method in MALDI-TOF/TOF Mass SpectrometryMolecular & Cellular Proteomics, 2006
- Predicting the outcome of chemotherapy for colorectal cancerCurrent Opinion in Pharmacology, 2006
- Essential and mutually compensatory roles of α-mannosidase II and α-mannosidase IIx in N -glycan processing in vivo in miceProceedings of the National Academy of Sciences, 2006
- Galectin Binding to Mgat5-Modified N-Glycans Regulates Fibronectin Matrix Remodeling in Tumor CellsMolecular and Cellular Biology, 2006
- Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinomaInternational Journal of Clinical Oncology, 2003
- Resistance to 5-FluorouracilGeneral Pharmacology: The Vascular System, 1998
- Structure analyses of oligosaccharides by tagging of the reducing end sugars with a fluorescent compoundBiochemical and Biophysical Research Communications, 1978